Investigation of cognitive dysfunction in patients with advanced skin cancer undergoing systemic therapy
- Conditions
- C43C44Malignant melanoma of skinOther malignant neoplasms of skin
- Registration Number
- DRKS00034805
- Lead Sponsor
- niversitätshautklinik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
• Diagnosis of a tumor of the skin, mucous membrane and/or skin appendages
OR
• Diagnosis of uveal melanoma
• Treatment at the study center
• Signed consent form from the patient or his/her caregiver
• First-line therapy for the melanoma
• Lack of consent form
• Known brain metastases
• Neurological diseases e.g. dementia
• (Active) drug use
• Current use of medication with proven cognitive impairment
• Other cancer (second neoplasm) =2 years ago
• (Second) systemic anti-tumor therapy e.g. chemotherapy or previous immunotherapy
• Immunosuppression or immunodeficiency
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive performance as measured by the tests used in the study
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.